News

MediLynx Cardiac Monitoring, LLC Introduces Dedicated Remote Monitoring Services Based on its PocketECG® Platform to Support Hospitals Managing COVID-19 Patients
April 1, 2020
MediLynx Cardiac Monitoring, LLC, a national remote monitoring provider and a technology leader in deep learning artificial intelligence (AI), announced the introduction of dedicated services based on its PocketECG systems to help hospitals manage COVID-19 patients in all stages of the infection.
Groundbreaking Clinical Study Shows AI Image-Guided X-Ray Technology Sets a New Standard of Care, With a Median Dose Reduction to Patient and Staff of Over 60%
March 31, 2020
Manufacturers of Artificial Intell
ACC.20/WCC: Intravenous Sodium Nitrite Ineffective for Out-of-Hospital Cardiac Arrest
March 29, 2020
Among patients who had an out-of-hospital cardiac arrest, intravenous sodium nitrite given by paramedics during resuscitation did not significantly improve their chances of being admitted to or discharged from the hospital alive, according to research presented at the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
ACC.20/WCC: Renal Denervation Effective in Patients with Untreated Hypertension
March 29, 2020
Three months after undergoing renal denervation (RDN) — a procedure that delivers energy to overactive nerves leading to the kidney to decrease their activity — patients with untreated high blood pressure had statistically significant reductions in average blood pressure over 24 hours compared with patients who underwent a sham procedure and experienced no major adverse effects, according to re
ACC.20/WCC: LAAO Registry Shows Higher Success Rates, Lower Adverse Outcomes Than Clinical Trials
March 29, 2020
Patients undergoing left atrial appendage occlusion (LAAO) experienced higher success rates and lower rates of in-hospital major adverse events, compared with those reported in randomized clinical trials, according to results from Featured Clinical Research presented March 29 during ACC.2
ACC.20/WCC: WATCHMAN Shows Favorable Safety Record in US Clinical Practice
March 29, 2020
Procedures to implant the WATCHMAN left atrial occlusion device had a high implant success rate and a low rate of in-hospital complications in an analysis of more than 38,000 procedures presented at the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
ACC.20/ACC: Antiplatelet Drugs Increase Risk for TAVR Patients with Atrial Fibrillation
March 29, 2020
Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement (TAVR) had a lower rate of bleeding complications without an increased risk of clotting-related complications compared to patients who took antiplatelet medication in addition to oral anticoagulants, in a trial presented at the American College of Cardiology’s Annual Scie
ACC.20/WCC: Burnout a Major and Growing Issue Among Nation’s Cardiologists
March 28, 2020
More than 1 out of 3 heart doctors in the U.S. report feeling burned out, according to results of a new survey presented at the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
ACC.20/WCC: Vericiguat Improves Outcomes in Patients with Worsening Heart Failure
March 28, 2020
Patients with worsening heart failure and reduced ejection fraction who received the investigational drug vericiguat had a significantly lower rate of cardiovascular death or heart failure hospitalization compared with those receiving a placebo, based on research presented at the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes
March 28, 2020
Abbott announced that the U.S.